Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
113.40
+2.34 (2.11%)
Jul 21, 2026, 3:53 PM EDT - Market open
Kymera Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $120 → $140 | Buy | Maintains | $120 → $140 | +23.46% | Jul 16, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $140 | Buy | Maintains | $140 | +23.46% | Jul 16, 2026 |
| RBC Capital | RBC Capital | Hold Downgrades $106 → $115 | Hold | Downgrades | $106 → $115 | +1.41% | Jul 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $125 | Buy | Reiterates | $125 | +10.23% | Jun 30, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $116 → $136 | Buy | Reiterates | $116 → $136 | +19.93% | Jun 29, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $117 → $155 | Buy | Reiterates | $117 → $155 | +36.68% | Jun 29, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $106 → $129 | Buy | Reiterates | $106 → $129 | +13.76% | Jun 26, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Buy Reiterates $116 | Buy | Reiterates | $116 | +2.29% | Jun 26, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.